The U.S. Food and Drug Administration has given Bayer a priority review for its New Drug Application for copanlisib, a drug to be used for relapses of refractory follicular lymphoma in individuals who have had a minimum of two therapies. Read More »
Concert Pharmaceuticals Inc. has received a second request from the Federal Trade Commission for the acquisition of CTP-656, as well as other options for cystic fibrosis treatment, produced by Vertex Pharmaceuticals Inc. Read More »
Amgen announced May 18 a Biologics License Application which they submitted to the U.S. Food and Drug Administration for a migraine prevention medication. Read More »
CVS Pharmacy is launching a new campaign during the month of May, by the name of Long Live Skin. Read More »
Omnicell Inc, announced May 1 that they would be allowing patients of AcuDose-Rx Automated Dispensing Cabinets the ability to upgrade to the more specialty XT Series while using their current software. Read More »
Good Day Pharmacy COO, Vicki Einhellig took place in the recent National Community Pharmacists Association's Steering Committee Forum from April 25-26. Read More »
Amgen announced May 2 that they had signed an outcome-based refund contract with Harvard Pilgrim for Amgen's Repatha. Read More »
BiologicTx marked a year of successful transplants using its paired donation software, BiologicTx MatchGrid. Read More »
Pharmacy benefit managers are changing the way that prescriptions are filled, reducing the costs for patients and increasing the value for all involved. Read More »
Aytu BioScience Inc. has two new posters that exhibit the use of the MiOXSYS System, a tool developed by the company for determining oxidative stress in human semen. Read More »
Biologics Inc., a McKesson Specialty Health company, has been selected by Takeda Pharmaceutical Co. to be a “specialty pharmacy provider” for ALUNBRIG, a Takeda-manufactured drug for anaplastic lymphoma kinase positive metastatic non-small cell lung cancer. Read More »
The drug Kalydeco was recently approved to treat additional case of gene mutations in cystic fibrosis patients, the U.S. Food and Drug Administration reported on May 17 in a press release. Read More »
The FDA recently approved Abon Pharmaceuticals' Abbreviated New Drug Application for its Clofarabine Injection as a treatment for pediatric patients who suffer from relapsed or refractory acute lymphoblastic leukemia, a deadly cancer disease. Read More »
fred’s Pharmacy was pleased to report they screened over 98,000 people for heart disease and detection during their Heart Disease Awareness and Colorectal Cancer Campaigns, and made a huge donation of $38,244 to the American Heart Association this month. Read More »
Pennsylvania Physician General Dr. Rachel Levine and Dauphin County Coroner Graham Hetrick recently met to discuss prescribing guidelines for opioids and benzodiazepines, known as benzos, and the opioid epidemic. Read More »
60 Degrees Pharmaceuticals' study findings on tafenoquine have been published in Travel Medicine and Infectious Disease. Read More »
Express Scripts has acquired myMatrixx to combine its integrated pharmacy benefit management services with myMatrixx's workers' compensation pharmacy benefits experience. Read More »
Sandoz AG, part of Novatis, has made an agreement with DURECT Corp. for the marketing of POSIMIR, an analgesic being developed by DURECT. Read More »
GE Healthcare is working alongside of Check-Cap on the development and validation of a cancer-screening process. Read More »
Portola Pharmaceuticals Inc.'s clinical results from a study will be presented during the International Conference on Malignant Lymphoma. Read More »
Alerts Sign-up
